0.3850USD+5.48%Mkt Cap: 3.29M USDP/E: 2.50Last update: 2026-05-22
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology …
Industry Peers
Drug Manufacturers - Specialty & Generic152.45BSEKP/E 166.3
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BEURP/E 30.3
Indicators:|
Key Statistics
Company
Market Cap3.29M USD
Enterprise Value61.84M USD
Revenue (TTM)257.55M USD
Gross Profit221.67M USD
Net Income (TTM)35.64M USD
Revenue/Share19.68 USD
Last Price0.3850 USD
Fiscal Year EndDec 2022
MR QuarterJun 2023
Employees134
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS2697961082
Valuation
P/E (Trailing)2.50
P/E (Forward)0.07
PEG—
EV/EBITDA0.99
EV/Revenue0.24
P/S0.01
P/B0.01
EPS (TTM)0.10
EPS (Forward)3.48
52W Range
0.001010% of range3.870
52W High3.870 USD
52W Low0.0010 USD
Profitability
Gross Margin70.01%
Oper. Margin15.94%
EBITDA Margin24.20%
Profit Margin11.26%
ROE15.26%
ROA8.78%
Growth
Revenue Growth-12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.70M USD
CapEx (TTM)178.00K USD
FCF Margin14.88%
FCF Yield1164.80%
Net Debt57.10M USD
Net Debt/EBITDA0.92
Balance Sheet
Debt/Equity0.27
Current Ratio2.16
Quick Ratio1.51
Book Value/Sh19.25 USD
Cash/Share1.182 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.16M
Float5.91M
Insiders0.00%
Institutions55.20%
Short Interest
Short Ratio3.9d
Short % Float4.19%
Short % Out.2.71%
Shares Short350.53K
Short (prev mo.)484.16K
Technical
SMA 500.3137 (+22.7%)
SMA 2001.107 (-65.2%)
Beta0.60
S&P 52W Chg28.31%
Avg Vol (30d)490
Avg Vol (10d)410
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—